Continuous cultures of fused cells secreting antibody of predefined specificity

The Human Plasma Proteome

Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414

The human cell atlas

Regev, A., Teichmann, S. A., Lander, E. S., Amit, I., Benoist, C., Birney, E., Bodenmiller, B., Campbell, P., Carninci, P., Clatworthy, M., et al. (2017) · eLife · doi:10.7554/elife.27041 · Cited by 2,232

Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731

Antibody drug conjugate: the “biological missile” for targeted cancer therapy

Fu, Z., Li, S., Han, S., Shi, C., & Zhang, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00947-7 · Cited by 1,643

Therapeutic antibodies: successes, limitations and hopes for the future

Chames, P., Van Regenmortel, M., Weiss, E., & Baty, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00190.x · Cited by 1,382

Bispecific antibodies: a mechanistic review of the pipeline

Labrijn, A. F., Janmaat, M. L., Reichert, J. M., & Parren, P. W. H. I. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0028-1 · Cited by 1,303

RNA therapeutics: beyond RNA interference and antisense oligonucleotides

Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152

Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor

Takeshima, H., Nishimura, S., Matsumoto, T., Ishida, H., Kangawa, K., Minamino, N., Matsuo, H., Ueda, M., Hanaoka, M., Hirose, T., et al. (1989) · Nature · doi:10.1038/339439a0 · Cited by 1,146

DNA vaccines: ready for prime time?

Kutzler, M. A., & Weiner, D. B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2432 · Cited by 1,077

Switches in expression of plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes

Smith, J. D., Chitnis, C. E., Craig, A. G., Roberts, D. J., Hudson-Taylor, D. E., Peterson, D. S., Pinches, R., Newbold, C. I., & Miller, L. H. (1995) · Cell · doi:10.1016/0092-8674(95)90056-x · Cited by 1,005

Monoclonal Antibody Pharmacokinetics and Pharmacodynamics

Wang, W., Wang, E., & Balthasar, J. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.170 · Cited by 978

Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy

Chari, R. V. J., Miller, M. L., & Widdison, W. C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201307628 · Cited by 930

Antibody Pharmacokinetics and Pharmacodynamics

Lobo, E. D., Hansen, R. J., & Balthasar, J. P. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20178 · Cited by 909

IgA Response to Symbiotic Bacteria as a Mediator of Gut Homeostasis

Peterson, D. A., McNulty, N. P., Guruge, J. L., & Gordon, J. I. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.09.013 · Cited by 828

Glycosylation as a strategy to improve antibody-based therapeutics

Jefferis, R. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2804 · Cited by 829

Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies

Keizer, R. J., Huitema, A. D. R., Schellens, J. H. M., & Beijnen, J. H. (2010) · Clinical Pharmacokinetics · doi:10.2165/11531280-000000000-00000 · Cited by 725

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697

Reproducibility: Standardize antibodies used in research

Bradbury, A., & Plückthun, A. (2015) · Nature · doi:10.1038/518027a · Cited by 647

Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations

Hoos, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.35 · Cited by 601

Polymeric nanomedicine for cancer therapy

Park, J. H., Lee, S., Kim, J.-H., Park, K., Kim, K., & Kwon, I. C. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.09.003 · Cited by 506

Targeted delivery of nanoparticles for the treatment of lung diseases

Azarmi, S., Roa, W. H., & Löbenberg, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.006 · Cited by 440

Human antibodies from transgenic animals.

Lonberg, N. (2005) · Nature Biotechnology · doi:10.1038/nbt1135 · Cited by 434

Molecular basis of biomaterial-mediated foreign body reactions

Hu, W.-J., Eaton, J. W., Ugarova, T. P., & Tang, L. (2001) · Blood · doi:10.1182/blood.v98.4.1231 · Cited by 431

Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins

Liu, L. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24444 · Cited by 428

Phosphorylation determines two distinct species of tau in the central nervous system

Papasozomenos, S. C., & Binder, L. I. (1987) · Cell Motility · doi:10.1002/cm.970080303 · Cited by 420

Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics

Boswell, C. A., Tesar, D. B., Mukhyala, K., Theil, F.-P., Fielder, P. J., & Khawli, L. A. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100261d · Cited by 398

Antibody-targeted radiation cancer therapy

Milenic, D. E., Brady, E. D., & Brechbiel, M. W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1413 · Cited by 380

DNA-Encoded Chemical Libraries: A Selection System Based on Endowing Organic Compounds with Amplifiable Information

Neri, D., & Lerner, R. A. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012550 · Cited by 364

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis.

Yano, K., Tsuda, E., Washida, N., Kobayashi, F., Goto, M., Harada, A., Ikeda, K., Higashio, K., & Yamada, Y. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.4.518 · Cited by 363

Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia

Beisiegel, U., Schneider, W. J., Goldstein, J. L., Anderson, R. G., & Brown, M. S. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68494-2 · Cited by 357

Therapies for rare diseases: therapeutic modalities, progress and challenges ahead

Tambuyzer, E., Vandendriessche, B., Austin, C. P., Brooks, P. J., Larsson, K., Miller Needleman, K. I., Valentine, J., Davies, K., Groft, S. C., Preti, R., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0049-9 · Cited by 357

Human myeloid leukemia cell lines: a review

Koeffler, H., & Golde, D. (1980) · Blood · doi:10.1182/blood.v56.3.344.344 · Cited by 349

Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Major sialoglycoproteins carrying polylactosaminoglycan.

Carlsson, S. R., Roth, J., Piller, F., & Fukuda, M. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37369-1 · Cited by 345

Bispecific antibodies for cancer therapy: The light at the end of the tunnel?

Chames, P., & Baty, D. (2009) · mAbs · doi:10.4161/mabs.1.6.10015 · Cited by 336

Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region

Schlepckow, K., Monroe, K. M., Kleinberger, G., Cantuti‐Castelvetri, L., Parhizkar, S., Xia, D., Willem, M., Werner, G., Pettkus, N., Brunner, B., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911227 · Cited by 324

Antibody–Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review

Lambert, J. M., & Morris, C. Q. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0519-6 · Cited by 304

Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development

Ovacik, M., & Lin, K. (2018) · Clinical and Translational Science · doi:10.1111/cts.12567 · Cited by 299

SNAP-25, a t-SNARE which binds to both syntaxin and synaptobrevin via domains that may form coiled coils.

Chapman, E. R., An, S., Barton, N., & Jahn, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47003-2 · Cited by 295

Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells

Reddy, S. T., Ge, X., Miklos, A. E., Hughes, R. A., Kang, S. H., Hoi, K. H., Chrysostomou, C., Hunicke-Smith, S. P., Iverson, B. L., Tucker, P. W., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1673 · Cited by 292

Serum therapy revisited: animal models of infection and development of passive antibody therapy

Casadevall, A., & Scharff, M. D. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1695 · Cited by 251

Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies

Green, L. L. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00137-4 · Cited by 229

How mRNA therapeutics are entering the monoclonal antibody field

Van Hoecke, L., & Roose, K. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1804-8 · Cited by 205

Double-Cone Localization and Seasonal Expression Pattern Suggest a Role in Magnetoreception for European Robin Cryptochrome 4

Günther, A., Einwich, A., Sjulstok, E., Feederle, R., Bolte, P., Koch, K.-W., Solov’yov, I. A., & Mouritsen, H. (2018) · Current Biology · doi:10.1016/j.cub.2017.12.003 · Cited by 204

Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies

Wang, X., Das, T. K., Singh, S. K., & Kumar, S. (2009) · mAbs · doi:10.4161/mabs.1.3.8035 · Cited by 198

abYsis: integrated antibody sequence and structure-management, analysis, and prediction

Swindells, M. B., Porter, C. T., Couch, M., Hurst, J., Abhinandan, K. R., Nielsen, J. H., Macindoe, G., Hetherington, J., & Martin, A. C. R. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.08.019 · Cited by 184

Guidelines to cell engineering for monoclonal antibody production

Rita Costa, A., Elisa Rodrigues, M., Henriques, M., Azeredo, J., & Oliveira, R. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.10.002 · Cited by 178

RNA editing: Expanding the potential of RNA therapeutics

Booth, B. J., Nourreddine, S., Katrekar, D., Savva, Y., Bose, D., Long, T. J., Huss, D. J., & Mali, P. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.01.005 · Cited by 171

Single-Cell Genomics: A Stepping Stone for Future Immunology Discoveries

Giladi, A., & Amit, I. (2018) · Cell · doi:10.1016/j.cell.2017.11.011 · Cited by 168

mRNA mediates passive vaccination against infectious agents, toxins, and tumors

Thran, M., Mukherjee, J., Pönisch, M., Fiedler, K., Thess, A., Mui, B. L., Hope, M. J., Tam, Y. K., Horscroft, N., Heidenreich, R., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707678 · Cited by 166

Fully human therapeutic monoclonal antibodies.

Weiner, L. M. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000192105.24583.83 · Cited by 164

A revival of bispecific antibodies

Kufer, P., Lutterbüse, R., & Baeuerle, P. A. (2004) · Trends in Biotechnology · doi:10.1016/j.tibtech.2004.03.006 · Cited by 157

The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics

Qian, L., Lin, X., Gao, X., Khan, R. U., Liao, J.-Y., Du, S., Ge, J., Zeng, S., & Yao, S. Q. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00915 · Cited by 155

Targeted α-therapy–past, present, future?

Brechbiel, M. W. (2007) · Dalton Transactions · doi:10.1039/b704726f · Cited by 151

The 39-kDa receptor-associated protein interacts with two members of the low density lipoprotein receptor family, alpha 2-macroglobulin receptor and glycoprotein 330.

Kounnas, M. Z., Argraves, W. S., & Strickland, D. K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36811-5 · Cited by 151

Animal immunization, in vitro display technologies, and machine learning for antibody discovery

Laustsen, A. H., Greiff, V., Karatt-Vellatt, A., Muyldermans, S., & Jenkins, T. P. (2021) · Trends in Biotechnology · doi:10.1016/j.tibtech.2021.03.003 · Cited by 147

Developments and Challenges for mAb-Based Therapeutics

Goswami, S., Wang, W., Arakawa, T., & Ohtake, S. (2013) · Antibodies · doi:10.3390/antib2030452 · Cited by 144

Neuropeptide and small transmitter coexistence: Fundamental studies and relevance to mental illness

Hökfelt, T., Barde, S., Xu, Z.-Q. D., Kuteeva, E., Rüegg, J., Le Maitre, E., Risling, M., Kehr, J., Ihnatko, R., Theodorsson, E., et al. (2018) · Frontiers in Neural Circuits · doi:10.3389/fncir.2018.00106 · Cited by 139

Immunotherapy for the treatment of drug abuse

Kosten, T., & Owens, S. M. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.009 · Cited by 135

Therapeutic Antibodies: Current State and Future Trends – Is a Paradigm Change Coming Soon?

Dimitrov, D. S., & Marks, J. D. (2009) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-554-1_1 · Cited by 132

Advances in animal cell recombinant protein production: GS-NS0 expression system

Barnes, L. M., Bentley, C. M., & Dickson, A. J. (2000) · Cytotechnology · doi:10.1023/a:1008170710003 · Cited by 129

Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide

Dromer, F., Salamero, J., Contrepois, A., Carbon, C., & Yeni, P. (1987) · Infection and Immunity · doi:10.1128/iai.55.3.742-748.1987 · Cited by 128

Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons

Pigoni, M., Wanngren, J., Kuhn, P.-H., Munro, K. M., Gunnersen, J. M., Takeshima, H., Feederle, R., Voytyuk, I., De Strooper, B., Levasseur, M. D., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0134-z · Cited by 125

The illusion of cell immortality

Hayflick, L. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1296 · Cited by 124

Immunosensors: Antibody-based biosensors

North, J. R. (1985) · Trends in Biotechnology · doi:10.1016/0167-7799(85)90119-2 · Cited by 123

When monoclonal antibodies are not monospecific: hybridomas frequently express additional functional variable regions

Bradbury, A. R. M., Trinklein, N. D., Thie, H., Wilkinson, I. C., Tandon, A. K., Anderson, S., Bladen, C. L., Jones, B., Aldred, S. F., Bestagno, M., et al. (2018) · mAbs · doi:10.1080/19420862.2018.1445456 · Cited by 121

Animal-derived products in science and current alternatives

Duarte, A. C., Costa, E. C., Filipe, H. A. L., Saraiva, S. M., Jacinto, T., Miguel, S. P., Ribeiro, M. P., & Coutinho, P. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213428 · Cited by 117

Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice

Mentzel, S., Dijkman, H. B., Van Son, J. P., Koene, R. A., & Assmann, K. J. (1996) · Journal of Histochemistry & Cytochemistry · doi:10.1177/44.5.8627002 · Cited by 108

Monoclonal antibodies for prophylactic and therapeutic use against viral infections

Both, L., Banyard, A. C., van Dolleweerd, C., Wright, E., Ma, J. K.-C., & Fooks, A. R. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.01.025 · Cited by 107

Increasing disparities between resource inputs and outcomes, as measured by certain health deliverables, in biomedical research

Bowen, A., & Casadevall, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504955112 · Cited by 104

A human endothelial cell-based recycling assay for screening of FcRn targeted molecules

Grevys, A., Nilsen, J., Sand, K. M. K., Daba, M. B., Øynebråten, I., Bern, M., McAdam, M. B., Foss, S., Schlothauer, T., Michaelsen, T. E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03061-x · Cited by 98

OptCDR: a general computational method for the design of antibody complementarity determining regions for targeted epitope binding

Pantazes, R. J., & Maranas, C. D. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq061 · Cited by 97

The coming of age of liquid chromatography coupled to tandem mass spectrometry in the endocrinology laboratory

Carvalho, V. M. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.08.027 · Cited by 90

History of Cell Culture

Jedrzejczak-Silicka, M. (2017) · New Insights into Cell Culture Technology · doi:10.5772/66905 · Cited by 87

Monoclonal Antibodies Selective for Low Molecular Weight Neurofilaments

Norgren, N., Karlsson, J.-E., Rosengren, L., & Stigbrand, T. (2002) · Hybridoma and Hybridomics · doi:10.1089/15368590252917647 · Cited by 81

Fc Sialylation Prolongs Serum Half-Life of Therapeutic Antibodies

Bas, M., Terrier, A., Jacque, E., Dehenne, A., Pochet-Béghin, V., Beghin, C., Dezetter, A.-S., Dupont, G., Engrand, A., Beaufils, B., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800896 · Cited by 82

The European Hematology Association Roadmap for European Hematology Research: a consensus document

Engert, A., Balduini, C., Brand, A., Coiffier, B., Cordonnier, C., Dohner, H., de Wit, T. D., Eichinger, S., Fibbe, W., Green, T., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.136739 · Cited by 81

Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis

Höftberger, R., Fink, S., Aboul‐Enein, F., Botond, G., Olah, J., Berki, T., Ovadi, J., Lassmann, H., Budka, H., & Kovacs, G. G. (2010) · Glia · doi:10.1002/glia.21054 · Cited by 79

Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay

Hoefig, C. S., Köhrle, J., Brabant, G., Dixit, K., Yap, B., Strasburger, C. J., & Wu, Z. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2680 · Cited by 78

Human Monoclonal Antibodies: The Benefits of Humanization

Waldmann, H. (2019) · Methods in Molecular Biology · doi:10.1007/978-1-4939-8958-4_1 · Cited by 80

Mouse cell line authentication

Almeida, J. L., Hill, C. R., & Cole, K. D. (2014) · Cytotechnology · doi:10.1007/s10616-013-9545-7 · Cited by 75

Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview

Polito, L., Djemil, A., & Bortolotti, M. (2016) · Biomedicines · doi:10.3390/biomedicines4020012 · Cited by 75

Aducanumab—Hope or Disappointment for Alzheimer’s Disease

Wojtunik-Kulesza, K., Rudkowska, M., & Orzeł-Sajdłowska, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054367 · Cited by 73

Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits

Bader, V., Tomppo, L., Trossbach, S. V., Bradshaw, N. J., Prikulis, I., Leliveld, S. R., Lin, C.-Y., Ishizuka, K., Sawa, A., Ramos, A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds273 · Cited by 70

Projecting human pharmacokinetics of monoclonal antibodies from nonclinical data: comparative evaluation of prediction approaches in early drug development

Wang, J., Iyer, S., Fielder, P. J., Davis, J. D., & Deng, R. (2016) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1952 · Cited by 69

Thyrotropin Isoforms: Implications for Thyrotropin Analysis and Clinical Practice

Estrada, J. M., Soldin, D., Buckey, T. M., Burman, K. D., & Soldin, O. P. (2014) · Thyroid® · doi:10.1089/thy.2013.0119 · Cited by 64

Biological anti-TNF drugs: immunogenicity underlying treatment failure and adverse events

Prado, M. S., Bendtzen, K., & Andrade, L. E. C. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1360280 · Cited by 58

Detection of 3,5-diiodothyronine in sera of patients with altered thyroid status using a new monoclonal antibody-based chemiluminescence immunoassay

Lehmphul, I., Brabant, G., Wallaschofski, H., Ruchala, M., Strasburger, C. J., Köhrle, J., & Wu, Z. (2014) · Thyroid® · doi:10.1089/thy.2013.0688 · Cited by 58

Heat Shock 70‐kDa Protein 8 Isoform 1 Is Expressed on the Surface of Human Embryonic Stem Cells and Downregulated upon Differentiation

Son, Y. S., Park, J. H., Kang, Y. K., Park, J., Choi, H. S., Lim, J. Y., Lee, J. E., Lee, J. B., Ko, M. S., Kim, Y., et al. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0307 · Cited by 54

Assessments of antibody biodistribution

Glassman, P. M., Abuqayyas, L., & Balthasar, J. P. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.365 · Cited by 42

Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy

Li, D., Bentley, C., Anderson, A., Wiblin, S., Cleary, K. L. S., Koustoulidou, S., Hassanali, T., Yates, J., Greig, J., Nordkamp, M. O., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3247 · Cited by 38

‘Zipbody’ leucine zipper-fused Fab in E. coli in vitro and in vivo expression systems

Ojima-Kato, T., Fukui, K., Yamamoto, H., Hashimura, D., Miyake, S., Hirakawa, Y., Yamasaki, T., Kojima, T., & Nakano, H. (2016) · Protein Engineering Design and Selection · doi:10.1093/protein/gzw001 · Cited by 35

A novel selection strategy for antibody producing hybridoma cells based on a new transgenic fusion cell line

Listek, M., Hönow, A., Gossen, M., & Hanack, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-58571-w · Cited by 34

Formation and Immunological Properties of Aldehyde-derived Protein Adducts following Alcohol Consumption

Thiele, G. M., Klassen, L. W., & Tuma, D. J. (2008) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-242-7_17 · Cited by 33

Application of immunochemical assays to food analysis

Gazzaz, S. S., Rasco, B. A., & Dong, F. M. (1992) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408399209527597 · Cited by 32

Mouse brain proteomics establishes MDGA1 and CACHD1 as in vivo substrates of the Alzheimer protease BACE1

Rudan Njavro, J., Klotz, J., Dislich, B., Wanngren, J., Shmueli, M. D., Herber, J., Kuhn, P., Kumar, R., Koeglsperger, T., Conrad, M., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902347r · Cited by 28

Engineering humoral immunity as prophylaxis or therapy

Deal, C. E., & Balazs, A. B. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.06.014 · Cited by 27

Serum Haptoglobin-Matrix Metalloproteinase 9 (Hp-MMP 9) Complex as a Biomarker of Systemic Inflammation in Cattle

Bannikov, G. A., Hinds, C. A., Rajala-Schultz, P. J., Premanandan, C., Rings, D. M., & Lakritz, J. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2010.08.004 · Cited by 25

Immunogenic properties of amyloid beta oligomers

Dalgediene, I., Lasickiene, R., Budvytyte, R., Valincius, G., Morkuniene, R., Borutaite, V., & Zvirbliene, A. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-10 · Cited by 22

In Vitro Antibody Affinity Maturation Targeting Germline Hotspots

Ho, M., & Pastan, I. (2009) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-554-1_15 · Cited by 21

Preparation of single-chain Fv antibodies in the cytoplasm of Escherichia coli by simplified and systematic chaperone optimization

Liu, C., Kobashigawa, Y., Yamauchi, S., Toyota, Y., Teramoto, M., Ikeguchi, Y., Fukuda, N., Sato, T., Sato, Y., Kimura, H., et al. (2019) · The Journal of Biochemistry · doi:10.1093/jb/mvz059 · Cited by 15